作者: Rong-Fu Wang , Helen Y. Wang
DOI: 10.1007/978-1-4419-9914-6_21
关键词:
摘要: The importance of T-cell-mediated antitumor immunity has been demonstrated in both animal models and human cancer immunotherapy. identification tumor antigens from various types generated a resurgence interest immunotherapy for provides the stage to develop therapeutic vaccines. However, recent clinical studies indicate that by peptide or DC/peptide vaccines is not sufficient eradicate cancer. One major factors weak transient immune response presence suppression microenvironment. Regulatory T cells myeloid-derived suppressor are cell responsible suppression. Novel strategies have developed enhancing T-cell responses against overcoming Combination antigen-specific stimulate effector with anti-immune opportunities developing effective